• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

据报告，肺动静脉畸形栓塞术可改善遗传性出血性毛细血管扩张症患者亚组的鼻出血症状。

Embolisation of PAVMs reported to improve nosebleeds by a subgroup of patients with hereditary haemorrhagic telangiectasia.

作者信息

Shovlin Claire L, Patel Trishan, Jackson James E

机构信息

NHLI Cardiovascular Sciences, Imperial College London, London, UK.

NHLI Cardiovascular Sciences, Imperial College London, London, UK; Dept of Medicine, St George's, University of London, London, UK.

出版信息

ERJ Open Res. 2016 Apr 29;2(2). doi: 10.1183/23120541.00035-2016. eCollection 2016 Apr.

DOI:10.1183/23120541.00035-2016
PMID:27730189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5005172/
Abstract

http://ow.ly/4mJqip.

摘要

网址链接无法直接翻译为中文，它只是一个网络地址，你可以告知我该网址对应的页面内容，以便我为你准确翻译相关文本。仅“http://ow.ly/4mJqip.”本身无法进行有意义的翻译。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda6/5005172/ff20b2c6884a/00035-2016.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda6/5005172/ff20b2c6884a/00035-2016.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eda6/5005172/ff20b2c6884a/00035-2016.01.jpg

相似文献

1
Embolisation of PAVMs reported to improve nosebleeds by a subgroup of patients with hereditary haemorrhagic telangiectasia.据报告，肺动静脉畸形栓塞术可改善遗传性出血性毛细血管扩张症患者亚组的鼻出血症状。
ERJ Open Res. 2016 Apr 29;2(2). doi: 10.1183/23120541.00035-2016. eCollection 2016 Apr.
2
Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.缺血性中风/脑脓肿风险的主要决定因素与遗传性出血性毛细血管扩张症中肺动静脉畸形的严重程度无关。
Thorax. 2008 Mar;63(3):259-66. doi: 10.1136/thx.2007.087452. Epub 2007 Nov 2.
3
Clinical Practice Guideline: Nosebleed (Epistaxis).临床实践指南：鼻出血（鼻衄）。
Otolaryngol Head Neck Surg. 2020 Jan;162(1_suppl):S1-S38. doi: 10.1177/0194599819890327.
4
Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.临床实践指南：鼻出血（鼻衄）执行摘要。
Otolaryngol Head Neck Surg. 2020 Jan;162(1):8-25. doi: 10.1177/0194599819889955.
5
Follow-up interval for small untreated pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中小的未经治疗的肺动静脉畸形的随访间隔
Clin Radiol. 2017 Mar;72(3):236-241. doi: 10.1016/j.crad.2016.12.002. Epub 2016 Dec 29.
6
Silent threat? A retrospective study of screening practices for pulmonary arteriovenous malformations in patients with hereditary haemorrhagic telangiectasia.无声的威胁？遗传性出血性毛细血管扩张症患者肺动静脉畸形筛查实践的回顾性研究。
Rhinology. 2012 Sep;50(3):277-83. doi: 10.4193/Rhino12.043.
7
Experience of the Irish National Centre for hereditary haemorrhagic telangiectasia 2003-2008.爱尔兰国家遗传性出血性毛细血管扩张症中心 2003-2008 年的经验。
Respir Med. 2010 Aug;104(8):1218-24. doi: 10.1016/j.rmed.2010.03.003. Epub 2010 Apr 1.
8
Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症肺右向左分流的随访。
Eur Respir J. 2016 Jun;47(6):1750-7. doi: 10.1183/13993003.01588-2015. Epub 2016 Mar 10.
9
Endovascular treatment of pulmonary and cerebral arteriovenous malformations in patients affected by hereditary haemorrhagic teleangiectasia.遗传性出血性毛细血管扩张症患者肺和脑动静脉畸形的血管内治疗
Curr Pharm Des. 2006;12(10):1243-8. doi: 10.2174/138161206776361237.
10
Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational study.遗传性出血性毛细血管扩张症患者膳食补充剂的使用与鼻出血——一项观察性研究
Intractable Rare Dis Res. 2016 May;5(2):109-13. doi: 10.5582/irdr.2016.01019.

引用本文的文献

1
Endogenous plasma resuspension of peripheral blood mononuclear cells prevents preparative-associated stress that modifies polyA-enriched RNA responses to subsequent acute stressors.外周血单核细胞的内源性血浆再悬浮可预防预处理相关应激，这种应激会改变富含多聚腺苷酸的RNA对后续急性应激源的反应。
Cell Stress. 2024 Nov 28;11:112-124. doi: 10.15698/cst2024.11.301. eCollection 2024.
2
Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT.导致提前终止密码子的突变可区分并产生 HHT 的细胞和临床变异性。
Blood. 2024 May 30;143(22):2314-2331. doi: 10.1182/blood.2023021777.
3

本文引用的文献

1
Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?铁剂治疗会加重某些遗传性出血性毛细血管扩张症患者的鼻出血吗？
Laryngoscope. 2016 Nov;126(11):2468-2474. doi: 10.1002/lary.25959. Epub 2016 Apr 23.
2
Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within Minutes.低剂量铁处理在数分钟内可诱导人内皮细胞发生DNA损伤反应。
PLoS One. 2016 Feb 11;11(2):e0147990. doi: 10.1371/journal.pone.0147990. eCollection 2016.
3
Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia.
Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction.
遗传性出血性毛细血管扩张症的致病变异频率支持预防心肌梗死的临床证据。
J Clin Med. 2023 Dec 31;13(1):250. doi: 10.3390/jcm13010250.
4
Unsupervised machine learning algorithms identify expected haemorrhage relationships but define unexplained coagulation profiles mapping to thrombotic phenotypes in hereditary haemorrhagic telangiectasia.无监督机器学习算法识别预期的出血关系，但定义了遗传性出血性毛细血管扩张症中与血栓形成表型相关的无法解释的凝血谱。
EJHaem. 2023 Jul 3;4(3):602-611. doi: 10.1002/jha2.746. eCollection 2023 Aug.
5
European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT).欧洲罕见血管疾病参考网络（VASCERN）遗传性出血性毛细血管扩张症（HHT）结局指标。
Orphanet J Rare Dis. 2018 Aug 15;13(1):136. doi: 10.1186/s13023-018-0850-2.
6
Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational study.遗传性出血性毛细血管扩张症患者膳食补充剂的使用与鼻出血——一项观察性研究
Intractable Rare Dis Res. 2016 May;5(2):109-13. doi: 10.5582/irdr.2016.01019.
遗传性出血性毛细血管扩张症中表型的循环因素
Front Genet. 2015 Apr 9;6:101. doi: 10.3389/fgene.2015.00101. eCollection 2015.
4
Pulmonary arteriovenous malformations.肺动静脉畸形
Am J Respir Crit Care Med. 2014 Dec 1;190(11):1217-28. doi: 10.1164/rccm.201407-1254CI.
5
Cardiopulmonary exercise testing demonstrates maintenance of exercise capacity in patients with hypoxemia and pulmonary arteriovenous malformations.心肺运动测试显示，在伴有低氧血症和肺动静脉畸形的患者中，运动能力得以维持。
Chest. 2014 Sep;146(3):709-718. doi: 10.1378/chest.13-2988.
6
Arterial oxygen content is precisely maintained by graded erythrocytotic responses in settings of high/normal serum iron levels, and predicts exercise capacity: an observational study of hypoxaemic patients with pulmonary arteriovenous malformations.在血清铁水平高/正常的情况下，动脉血氧含量通过分级红细胞增多反应精确维持，并可预测运动能力：一项对低氧血症性肺动静脉畸形患者的观察性研究。
PLoS One. 2014 Mar 17;9(3):e90777. doi: 10.1371/journal.pone.0090777. eCollection 2014.
7
Direct haemodynamic effects of pulmonary arteriovenous malformation embolisation.肺动静脉畸形栓塞的直接血液动力学效应。
Neth Heart J. 2014 Aug;22(7-8):328-33. doi: 10.1007/s12471-014-0539-7.
8
Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets.患有肺动静脉畸形和遗传性出血性毛细血管扩张症患者的缺血性中风：与缺铁和血小板的关联
PLoS One. 2014 Feb 19;9(2):e88812. doi: 10.1371/journal.pone.0088812. eCollection 2014.
9
Relationships between epistaxis, migraines, and triggers in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中鼻出血、偏头痛与诱发因素之间的关系。
Laryngoscope. 2014 Jul;124(7):1521-8. doi: 10.1002/lary.24526. Epub 2014 Jan 23.
10
Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency.经出血调整的铁需求、生血素和铁调素将遗传性出血性毛细血管扩张症定义为出血性缺铁的模型。
PLoS One. 2013 Oct 16;8(10):e76516. doi: 10.1371/journal.pone.0076516. eCollection 2013.